TRxADE HEALTH, Inc. (MEDS)
NASDAQ: MEDS · IEX Real-Time Price · USD
6.50
-0.16 (-2.40%)
At close: Apr 23, 2024, 4:00 PM
7.00
+0.50 (7.69%)
After-hours: Apr 23, 2024, 6:23 PM EDT
TRxADE HEALTH Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for TRxADE HEALTH stock have an average target of 18.75, which predicts an increase of 188.46% from the current stock price of 6.50.
Analyst Consensus: Strong Buy
* Price targets were last updated on Jun 1, 2023.
Analyst Ratings
The average analyst rating for TRxADE HEALTH stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '23 | Mar '23 | Apr '23 | May '23 | Jun '23 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| EF Hutton | EF Hutton | Strong Buy Initiates $19 | Strong Buy | Initiates | $19 | +188.46% | Jun 1, 2023 |
| EF Hutton | EF Hutton | Strong Buy Maintains $26 → $19 | Strong Buy | Maintains | $26 → $19 | +188.46% | May 16, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $38 → $26 | Strong Buy | Maintains | $38 → $26 | +303.85% | Mar 28, 2023 |
| EF Hutton | EF Hutton | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 9, 2021 |
Financial Forecast
Revenue This Year
9.11M
from 11.45M
Decreased by -20.41%
Revenue Next Year
9.49M
from 9.11M
Increased by 4.10%
EPS This Year
-1.07
from -6.15
EPS Next Year
-0.46
from -1.07
Revenue Forecast
| Revenue | 2023 | 2024 |
|---|---|---|
| High | 9.4M | 9.8M |
| Avg | 9.1M | 9.5M |
| Low | 8.8M | 9.1M |
Revenue Growth
| Revenue Growth | 2023 | 2024 |
|---|---|---|
| High | -18.1% | 7.2% |
| Avg | -20.4% | 4.1% |
| Low | -23.5% | 0.0% |
EPS Forecast
| EPS | 2023 | 2024 |
|---|---|---|
| High | -1.10 | -0.47 |
| Avg | -1.07 | -0.46 |
| Low | -1.03 | -0.44 |
EPS Growth
| EPS Growth | 2023 | 2024 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.